Apontis Pharma AG
XETRA:APPH
Apontis Pharma AG
Non-Reccuring Items
Apontis Pharma AG
Non-Reccuring Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Apontis Pharma AG
XETRA:APPH
|
Non-Reccuring Items
-€5.6m
|
CAGR 3-Years
-250%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Non-Reccuring Items
-$4.1m
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bayer AG
XETRA:BAYN
|
Non-Reccuring Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck KGaA
XETRA:MRK
|
Non-Reccuring Items
-€12m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Non-Reccuring Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Non-Reccuring Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Apontis Pharma AG
Glance View
APONTIS PHARMA AG engages in the development, promotion, and sale of single pills and other pharmaceutical products. The company is headquartered in Monheim Am Rhein, Nordrhein-Westfalen and currently employs 176 full-time employees. The company went IPO on 2021-05-11. The firm focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
See Also
What is Apontis Pharma AG's Non-Reccuring Items?
Non-Reccuring Items
-5.6m
EUR
Based on the financial report for Dec 31, 2023, Apontis Pharma AG's Non-Reccuring Items amounts to -5.6m EUR.
What is Apontis Pharma AG's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 3Y
-250%
The average annual Non-Reccuring Items growth rates for Apontis Pharma AG have been -250% over the past three years .
You don't have any saved screeners yet